Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Genes|November 30, 2018
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD VariantsCarin A T C Lunenburg, Linda M Henricks, André B P van Kuilenburg, et al.
Nature Cell Biology|May 26, 2015
RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growthPhilippe Depeille, Linda M Henricks, Robert A H van de Ven, et al.
Clinical Pharmacology and Therapeutics|November 21, 2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 UpdateUrsula Amstutz, Linda M Henricks, Steven M Offer, et al.
International Journal of Cancer|September 21, 2017
Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiencyLinda M Henricks, Ester J M Siemerink, Hilde Rosing, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2016
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidinesDidier Meulendijks, Linda M Henricks, André B P van Kuilenburg, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2018
Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriersCarin A T C Lunenburg, Linda M Henricks, Eva Dreussi, et al.
British Journal of Clinical Pharmacology|July 27, 2018
Food-effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteersLinda M Henricks, Bart A W Jacobs, Didier Meulendijks, et al.
Clinical Chemistry and Laboratory Medicine|August 31, 2022
Moving average quality control of routine chemistry and hematology parameters - a toolbox for implementationEsther van Andel, Linda M Henricks, Alex P M Giliams, et al.
British Journal of Cancer|April 21, 2017
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicityDidier Meulendijks, Linda M Henricks, Bart A W Jacobs, et al.
Pharmacogenomics|April 4, 2023
The Sixth European Society of Pharmacogenomics and Personalised Therapy CongressRon Hn van Schaik, Vangelis G Manolopoulos, Ann K Daly, et al.
Pageof 3